NewGenIvf Group Ltd(NIVF) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 0 | EPS (ttm) | 10104.35 | Insider Own | - | Shs Outstand | 1.2M | Perf Week | -26.09% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -75.85% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 0.07% | Short Float | - | Perf Quarter | -98.57% |
| Income | 0.00B | P/S | 0.23 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.23 | Perf Half Y | -99.8% |
| Sales | 0.00B | P/B | 0 | EPS next 5Y | - | ROA | 4.37% | Short Interest | 0.31M | Perf YTD | -99.96% |
| Book/sh | 733.75 | P/C | 1.03 | EPS past 3/5Y | -90.78% - | ROE | 6.27% | 52W High | -100% ($20908.80) | Perf Year | -99.99% |
| Cash/sh | 0.83 | P/FCF | - | Sales past 3/5Y | - | ROIC | 4.2% | 52W Low | -5.97% ($0.90) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 109.01% | Gross Margin | 13.81% | Volatility(W/M) | 11.45% 20.17% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.19 | Sales Y/Y TTM | - | Oper. Margin | -238.22% | ATR (14) | 1.44 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.98 | EPS Q/Q | -130.12% | Profit Margin | 24.16% | RSI (14) | 22.21 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.05 | Sales Q/Q | - | SMA20 | -50.23% ($1.71) | Beta | 0.14 | Target Price | $4066.56 |
| Payout | - | Debt/Eq | 0.06 | Earnings | 2026/09/02 | SMA50 | -94.82% ($16.41) | Rel Volume | 0.12 | Prev Close | $0.93 |
| Employees | 87 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -99.78% ($386.36) | Avg Volume(3M) | 1.34M | Price | $0.85 |
| IPO | 2022/3/18 | Option/Short | No/Yes | Trades | 554 | Volume | 163,769 | Change | -8.13% |
A healthcare company specializing in fertility treatment and assisted reproductive technology (ART) services. The company originated from operating fertility clinics in Asia and is now pursuing a business transformation toward a technology licensing platform. It has been strengthening its reproductive technology portfolio through acquisitions such as MicroSort.
Over the past 1 year, on the lower side
100% below its 1-year high.
Traded less than usual. That is 12% of its average volume.
NIVF has weak earning power
Losses exceed revenue. The business is barely earning yet.
Tap to view numbers
Relative to sales, it looks cheap
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $23. Peers typically go for $94.
Tap to view numbers
Holding long would have lost money
Bought 3 years ago, your return today would be -100.0%.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Institutions barely hold it
Institutions hold 0.1%.
Tap to view numbers
It ranks #48 of 48 in the industry
Based on market cap of $1M.
FAQ
What kind of company is NIVF?
NIVF belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of NIVF?
The market cap of NIVF is approximately $1M, ranking 5,869 within its sector.
What is the P/E ratio of NIVF?
NIVF has a P/E ratio of approximately 0.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NIVF?
NIVF has recorded a 52-week high of $20908.80 and a low of $0.90.
